Welcome to the New Website for Associated Industries of Fluoridate Voice of Florida Business!

Weekly Legislative Update from January 29, 2016

Health Care

SB 1686- Relating to Telehealth
On Tuesday, January 26th, SB 1686, relating to Telehealth, sponsored by Senator Aaron Bean (R-Jacksonville) was heard today by the Senate Health Policy Committee and unanimously passed with 9 yeas and 0 nays.

SB 1686 creates a Telehealth Task Force within the Agency for Health Care Administration (AHCA), authorizes healthcare practitioners in Florida to provide telehealth services, and defines telehealth. The task force is chaired by the Secretary of the AHCA or his or her designee, the State Surgeon General and 17 other members, including other health care practitioners, providers, telehealth services providers and sellers, and facilities.

The bill requires the task force to compile data and submit a report by June 30, 2017, to the Governor, the President of the Senate, and the Speaker of the House of Representatives that analyzes:

  • Frequency and extent of the use of telehealth nationally and in this state;
  • Costs and cost savings associated with using telehealth;
  • Types of telehealth services available;
  • Extent of available health insurance coverage available for telehealth services; and
  • Barriers to implementing the use of, using, or accessing telehealth services.


The bill requires the task force to hold its first meeting by September 1, 2016, and to meet as frequently as necessary to complete its work.

The next committee hearing for SB 1686 will be in the Senate Appropriations Subcommittee on Health and Human Services.

AIF supports legislation that permits an unfettered role for telehealth services that will allow our citizens access to better quality care at lower costs.

SB 676-Relating to Health Care
On Tuesday, January 26th, SB 676, relating to Health Care, by Senator Denise Grimsley (R-Sebring) was heard in front of the Senate Banking and Insurance Committee and passed with 9 yeas and 0 nays.

SB 676 would authorize and increase the scope for practice for physician assistants (PAs) and advanced registered nurse practitioners (ARNPs) to prescribe controlled substances under current supervisory standards for PAs and protocols for ARNPs beginning January 1, 2017.  ARNPs and Pas would not be allowed to prescribe controlled substances in a pain management clinic. Other provisions of the bill include:

  • Requiring health insurers, HMOs and pharmacy benefits managers to use the standardized prior authorization form by January 1, 2017;
  • Providing a health insurer or HMO cannot retroactively deny a claim due to an insured’s ineligibility, if that insurer or HMO verified eligibility at the time of treatment; and
  • Requiring hospitals to notify OB physicians with privileges at least 90 days prior to closing its OB department.

Another provision to the bill, which causes AIF to continue to express concern, is the provision that would prohibit a health insurer and health maintenance organization (HMO) from retroactively denying a claim due to the insured’s delinquency of premium payments, if that insurer or HMO already verified the insured’s eligibility at the time of treatment. This provision on claims payment could lead to increased costs on Florida’s businesses.

However, we do SUPPORT the provision in this bill that will provide for an increase of the scope of practice for ARNPs and PAs.

At this juncture AIF did not take a position on this bill.

The next committee stop for SB 676 is in the Senate Appropriations Subcommittee on Health and Human Services.